TESAMORELIN - Euro-Pharmacies

Tesamorelin, marketed as Egrifta, is a potent synthetic analog of growth hormone-releasing hormone (GHRH) that triggers the pituitary gland to release natural growth hormone in a controlled manner. Through its action on IGF-1, tesamorelin fosters reductions in visceral fat and waist circumference while supporting lean muscle growth. It is primarily prescribed for HIV patients with lipodystrophy but is also appreciated in fitness circles for its anabolic effects, as it helps preserve lean tissue during fat loss. Clinical trials show long-term effectiveness with elevated IGF-1 levels maintained for months, though mild side effects like injection site discomfort or water retention may occur in some users​.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about TESAMORELIN by Euro-Pharmacies, consult with your doctor or healthcare professional.